Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Motley Fool
Fri, 06/23/23 - 10:03 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
FDA
,
Leqembi
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Tags:
Roche
,
Angelman Syndrome
,
antisense
,
Biogen
,
Ionis Pharmaceuticals
,
Ultragenyx
,
rugonersen
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
Motley Fool
Mon, 06/19/23 - 10:21 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
Europe
On the Cusp of Full Approval, Leqembi’s Rollout Could Face Challenges
BioSpace
Fri, 06/16/23 - 10:01 am
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
FDA
,
Leqembi
The Biggest Barrier To New Anti-Alzheimer’s Drugs May Be Cost, Not Medicare Rules
Forbes
Wed, 06/14/23 - 06:42 pm
Tags:
Alzheimer's disease
,
drug pricing
,
Medicare
,
Biogen
,
Eisai
,
Leqembi
Biogen teams with NeuroSense to explore ALS neurofilament biomarker
BioSpace
Wed, 06/14/23 - 11:35 am
Tags:
Biogen
,
NeuroSense Therapeutics
,
ALS
,
PrimeC
Biogen Makes Changes to Board of Directors Ahead of Annual Shareholder Meeting
BioSpace
Tue, 06/13/23 - 10:44 am
Tags:
Biogen
How ALS Cell Models That Began In Blood Spurred An Encouraging Early-Stage Clinical Trial
Forbes
Mon, 06/12/23 - 10:08 am
Tags:
clinical trials
,
innovation
,
ALS
,
Parkinson's Disease
,
Biogen
FDA panel backs full approval for Eisai, Biogen Alzheimer’s drug
BioPharma Dive
Sun, 06/11/23 - 11:14 pm
Tags:
Eisai
,
Biogen
,
Leqembi
,
FDA
,
Alzheimer's disease
Eisai files Leqembi in Korea, as US prospects firm up
Pharmaphorum
Thu, 06/8/23 - 10:02 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
South Korea
,
Asia
Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 06/7/23 - 09:53 pm
Tags:
FDA
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate
Forbes
Wed, 06/7/23 - 09:34 pm
Tags:
Alzheimer's disease
,
FDA
,
insurance
,
Leqembia
,
Biogen
,
Eisai
,
Eli Lilly
,
donanemab
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Tags:
Merck
,
Inflation Reduction Act
,
legal
,
drug pricing
,
Biogen
,
Novartis
,
Genentech
,
BIO 2023
FDA Removes Expert with Ties to Eisai, Biogen from Leqembi Adcomm
BioSpace
Tue, 06/6/23 - 10:17 am
Tags:
FDA
,
Biogen
,
Eisai
,
Alzheimer's disease
,
Leqembi
Biogen scraps late-stage study for Parkinson’s drug
BioPharma Dive
Mon, 06/5/23 - 09:54 pm
Tags:
Biogen
,
clinical trials
,
Parkinson's Disease
,
BIIB122
PhRMA cries foul on CMS' registry approach for Alzheimer's disease drugs
Fierce Pharma
Sun, 06/4/23 - 04:15 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease Leqembi
,
CMS
,
PhRMA
Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs
Washington Post, DC
Fri, 06/2/23 - 10:18 am
Tags:
Medicare
,
Alzheimer's disease
,
Eisai
,
Biogen
,
Leqembi
Quanterix sees a bright future for blood biomarkers
EP Vantage
Fri, 06/2/23 - 10:08 am
Tags:
Biogen
,
Quanterix
,
diagnostics
,
Qalsody
,
ALS
,
biomarkers
The Alzheimer's pipeline is as strong as ever. Now, we just need the patients
Fierce Biotech
Wed, 05/31/23 - 07:02 pm
Tags:
Alzheimer's disease
,
patients
,
clinical trials
,
Biogen
,
Eisai
,
Eli Lilly
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.